Latest round: Growth. William Williams is the President and CEO of BriaCell Therapeutics, a clinical-stage biotechnology company focused on developing.
Dr. William Williams is the President and CEO of BriaCell Therapeutics, a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment. He is a biotechnology veteran who joined BriaCell in November 2016 as President, CEO, and Board Member, and previously held executive roles at GSK. Under his leadership, BriaCell has advanced its lead program Bria-IMT™ into Phase 3 clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library